PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
PURPOSE: Hypogonadism is a prominent risk factor for osteoporosis in older men. However, bone loss during androgen ablation therapy for prostate cancer has rarely been quantitated. MATERIALS AND METHODS: Femoral neck bone mineral density was determined in 26 men before orchiectomy or chemical castration as initial hormone therapy for prostate cancer and at 6-month intervals thereafter for 6 to 42 months. Measurements were made in 16 other men at 12 to 24 months beginning 3 to 8 years after the onset of castration. Baseline and post-castration bone loss was related to several host and tumor characteristics, and compared to similar measurements in 12 control subjects. RESULTS: Average age corrected baseline femoral neck bone mineral density was higher in controls than in treated men and remained essentially unchanged for 2 years. Following orchiectomy average bone mineral density decreased 2.4% and 7.6%, respectively, during years 1 and 2 (2-year loss 2.5% to 17.0%), with similar losses documented in men undergoing chemical castration. Average bone mineral density decreased 1.4% to 2.6% per year 3 to 8 years after uninterrupted androgen deprivation. Age corrected baseline bone mineral density was greater in men who were obese, younger than 75 years or participated in regular exercise but the influence of each characteristic could not be isolated. Post-castration bone loss was greater in men who were obese, younger than 75 years without regular exercise. CONCLUSIONS: Chemical or surgical castration in men with prostate cancer is usually followed by greatly accelerated bone loss which may be superimposed on a bone mass already depleted before hormonal therapy. Baseline bone mass and subsequent bone loss may be influenced by host obesity, age and exercise habits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O'Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 659
GENANT, H. K., CANN, C. E., ETTINGER, B., & GORDAN, G. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-699 · Cited by 656
Increased Estrogen Production in Obese Men*
SCHNEIDER, G., KIRSCHNER, M. A., BERKOWITZ, R., & ERTEL, N. H. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-4-633 · Cited by 506
ŠTĚPÁN, J. J., LACHMAN, M., ZVĚŘINA, J., PACOVSKÝ, V., & BAYLINK, D. J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-523 · Cited by 424
RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER
Krongrad, A., Levis, S., & Roos, B. A. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64271-x · Cited by 339
Osteoporosis After Orchiectomy for Prostate Cancer
Daniell, H. W. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65165-6 · Cited by 315
Self-citationRisk Factors for Hip Fracture in Middle-aged Norwegian Women and Men
Meyer, H. E., Tverdal, A., & Falch, J. A. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116622 · Cited by 306
Daniell (1976) · doi:10.1001/archinte.1976.03630030032007 · Cited by 301
Townsend, M. F., Sanders, W. H., Northway, R. O., & Graham, S. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<545::aid-cncr17>3.0.co;2-3 · Cited by 260
Menkes, A., Mazel, S., Redmond, R. A., Koffler, K., Libanati, C. R., Gundberg, C. M., Zizic, T. M., Hagberg, J. M., Pratley, R. E., & Hurley, B. F. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.74.5.2478 · Cited by 256
Diamond, T., Campbell, J., Bryant, C., & Lynch, W. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8<1561::aid-cncr11>3.0.co;2-z · Cited by 246
Kelepouris, N., Harper, K. D., Gannon, F., Kaplan, F. S., & Haddad, J. G. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-6-199509150-00010 · Cited by 201
Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens
Eriksson, S., Eriksson, A., Stege, R., & Carlstr�m, K. (1995) · Calcified Tissue International · doi:10.1007/bf00298427 · Cited by 191
The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone Metabolism
JOHANSEN, J. S., RIIS, B. J., HASSAGER, C., MOEN, M., JACOBSON, J., & CHRISTIANSEN, C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-701 · Cited by 189
Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study
Jackson, J. A., Riggs, M. W., & Spiekerman, A. M. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199207000-00003 · Cited by 183
Goldray, D. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.288 · Cited by 174
Influence of age and body weight on spine and femur bone mineral density in U.S. white men
Mazess, R. B., Barden, H. S., Drinka, P. J., Bauwens, S. F., Orwoll, E. S., & Bell, N. H. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050614 · Cited by 161
Bone Loss in Young Women With Karyotypically Normal Spontaneous Premature Ovarian Failure
Anasti, J. N., Kalantaridou, S. N., Kimzey, L. M., Defensor, R. A., & Nelson, L. M. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00583-8 · Cited by 146
Effects of strength training on bone mineral density: hormonal and bone turnover relationships
Ryan, A. S., Treuth, M. S., Rubin, M. A., Miller, J. P., Nicklas, B. J., Landis, D. M., Pratley, R. E., Libanati, C. R., Gundberg, C. M., & Hurley, B. F. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.4.1678 · Cited by 118
MATTA, W. H. M., Shaw, R. W., Hesp, R., & Katz, D. (1987) · BMJ · doi:10.1136/bmj.294.6586.1523 · Cited by 100
Flutamide-mediated androgen blockade evokes osteopenia in the female rat
Goulding, A., & Gold, E. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080615 · Cited by 76
SCHARLA, S. H., Minne, H. W., Waibel-Treber, S., Schaible, A., Lempert, U. G., Wüster, C. C., LEYENDECKER, G., & Ziegler, R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-1055 · Cited by 76
A Better Prognosis for Obese Men with Prostate Cancer
Daniell, H. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66599-6 · Cited by 35
Self-citationOsteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate
Collinson, M. P., TYRRELL, C. J., & Hutton, C. (1994) · Calcified Tissue International · doi:10.1007/bf00295959 · Cited by 31
Effects of three therapeutic regimens on postmenopausal bone loss in oophorectomized women
Luisetto, G., Bottega, F., Zangari, M., Tizian, L., Scalella, P., & Pozzuoli, A. (1996) · Current Therapeutic Research · doi:10.1016/s0011-393x(96)80017-8 · Cited by 7
Cited by
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Mohler, J., Bahnson, R. R., Boston, B., Busby, J. E., D'Amico, A., Eastham, J. A., Enke, C. A., George, D., Horwitz, E. M., Huben, R. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0012 · Cited by 897
Kirby, M., Hirst, C., & Crawford, E. D. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02799.x · Cited by 861
Metadata
- Authors
- DANIELL, H. W., DUNN, S. R., FERGUSON, D. W., LOMAS, G., NIAZI, Z., & STRATTE, P. T.
- Venue
- Journal of Urology
- Published
- 2000-01
- Volume
- 163
- Issue
- 1
- Pages
- 181-186
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W1974256738
- Cited by
- 452
- References
- 25
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.